Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Treatment of relapsed myeloma with novel targeted and immune therapies

Dr Kenneth Anderson - Dana–Farber Cancer Institute, Boston, USA
Treatment of relapsed myeloma with novel targeted and immune therapies ( Dr Kenneth Anderson - Dana–Farber Cancer Institute, Boston, USA )
5 May 2016

Targeting T regs in tumours

Dr Dario Vignali - University of Pittsburgh School of Medicine, Pittsburgh, USA
Targeting T regs in tumours ( Dr Dario Vignali - University of Pittsburgh School of Medicine, Pittsburgh, USA )
5 May 2016

Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity

Dr Thomas Dubensky - Aduro Biotech, Berkley, USA
Direct activation of STING in the tumour microenvironment leads to potent and systemic tumour regression and immunity ( Dr Thomas Dubensky - Aduro Biotech, Berkley, USA )
4 May 2016

Successes and challenges in designing combination immunotherapy clinical trials for breast cancer

Prof Leisha Emmens - Johns Hopkins Kimmel Cancer, Baltimore, USA
Successes and challenges in designing combination immunotherapy clinical trials for breast cancer ( Prof Leisha Emmens - Johns Hopkins Kimmel Cancer, Baltimore, USA )
4 May 2016

Understanding personalised medicine - the e-learning course

Prof Gordon McVie
Understanding personalised medicine - the e-learning course ( Prof Gordon McVie )
4 May 2016

Mechanisms of immune escape in non-Hodgkin lymphoma

Dr Riccardo Dalla-Favera - Columbia University Medical Center, New York, USA
Mechanisms of immune escape in non-Hodgkin lymphoma ( Dr Riccardo Dalla-Favera - Columbia University Medical Center, New York, USA )
4 May 2016

Comment on RESONATE2 and CLL115 trials

Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK
Comment on RESONATE2 and CLL115 trials ( Dr Peter Hillmen - Leeds Teaching Hospitals NHS Trust, Leeds, UK )
29 Apr 2016

Clinical cases employing novel agents in Hodgkin lymphoma

Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA
Clinical cases employing novel agents in Hodgkin lymphoma ( Dr Craig Moskowitz - Memorial Sloan Kettering Cancer Centre, New York, USA )
29 Apr 2016

Current trials in chronic lymphocytic leukaemia

Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Current trials in chronic lymphocytic leukaemia ( Dr George Follows - Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK )
29 Apr 2016

Chronic lymphocytic leukaemia: Transition to a new era

Prof Stephen Mulligan - Royal North Shore Hospital, Australia
Chronic lymphocytic leukaemia: Transition to a new era ( Prof Stephen Mulligan - Royal North Shore Hospital, Australia )
29 Apr 2016

p62: Metabolism and the tumour microenvironment

Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA
p62: Metabolism and the tumour microenvironment ( Prof Jorge Moscat - Sanford Burnahm Prebys Medical Discovery Institute, La Jolla, USA )
29 Apr 2016

Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma

Dr Paul Nghiem - University of Washington, Seattle, USA
Pembrolizumab yielded durable responses in patients with advanced Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )
28 Apr 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation